A retrospective study aimed to predict the efficacy of nivolumab based on a comprehensive analysis of RNA expression at the gene level in advanced Non-small cell lung cancer
Latest Information Update: 22 Mar 2022
At a glance
- Drugs Nivolumab (Primary)
- Indications Adenocarcinoma; Non-small cell lung cancer; Squamous cell cancer
- Focus Pharmacodynamics; Therapeutic Use
Most Recent Events
- 22 Mar 2022 New trial record
- 08 Feb 2022 Results published in the BMC Cancer